A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Genentech, Inc.
Genentech, Inc.
Incyte Corporation
Bristol-Myers Squibb
Travera Inc
7 Hills Pharma, LLC
OncoC4, Inc.
Merck Sharp & Dohme LLC
KaliVir Immunotherapeutics
Aulos Bioscience, Inc.
Bayer
AstraZeneca
Sotio Biotech Inc.
Pfizer
BeOne Medicines
Dragonfly Therapeutics
AstraZeneca
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Neonc Technologies, Inc.
ViroMissile, Inc.
Pfizer
Tizona Therapeutics, Inc
Shanghai Henlius Biotech
Werewolf Therapeutics, Inc.
MacroGenics
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
Novartis
Elephas
Inhibrx Biosciences, Inc
Incyte Corporation
Regeneron Pharmaceuticals
NeoTX Therapeutics Ltd.
AccSalus Biosciences, Inc.
LG Chem
OncoHost Ltd.
HiFiBiO Therapeutics
HiFiBiO Therapeutics
Bolt Biotherapeutics, Inc.
HiFiBiO Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
MacroGenics
Sichuan Baili Pharmaceutical Co., Ltd.
Novelty Nobility, Inc.
Pfizer
Asher Biotherapeutics, Inc.
Pfizer
Incyte Corporation
Guardant Health, Inc.